COVID Here comes COVID-19 version BA.2, BA.4, BA.5,...

  • Thread starter Thread starter Tom.G
  • Start date Start date
  • Tags Tags
    Covid-19
AI Thread Summary
The BA.2 variant of COVID-19 is showing increased transmissibility compared to the original BA.1 variant, with studies indicating that it may be more pathogenic and capable of evading vaccine-induced immunity. The CDC is actively monitoring BA.2, noting that there is currently no evidence suggesting it is more severe than BA.1. In the U.S., BA.2 has risen to account for nearly a quarter of new infections, particularly in the Northeast, where it has become dominant. New subvariants BA.2.12 and BA.2.12.1 have also emerged, showing a growth advantage and raising concerns due to additional mutations. Overall, the situation indicates a potential increase in cases, but the public health response continues to adapt as data evolves.
Biology news on Phys.org
  • #152
Astronuc said:
I'll be getting Covid (SARS-Cov-2) booster, Influenza and RSV simultaneously. I'll report on any reaction.

Meanwhile - Men at greater risk of severe Covid - and now experts may know why
https://www.msn.com/en-us/health/me...ovid-and-now-experts-may-know-why/ar-AA1hG5w9
See the PF thread on ACE-2 decoy.
https://www.physicsforums.com/threa...solution-to-covid-19-using-ace2-decoy.987905/
This seems to revisit an idea that they have been working on since 2020, the rational given in the article is simplistic and unhelpful. The protein products of ACEII expression are clearly important as the entry point of the SARS-CoV-2 virus into cells, it forms part of a functional biochemical network, it doesn't function in isolation. Its not clear why the fact many of the genes associated with immunity are on the X chromosome is important, it may be, but generally the second copy in women is epigenetically turned off. Then of course the presence of the gene doesn't really indicate its expression and that's what effects the protein product levels. In fact, the Genotype-Tissue Expression database reveals 15 e quantitative trait locus variants that regulate the expression of ACE2 in human and the presence of these variants occurs at different frequencies in different ethnic groups. While there do seem to be differences based on ethnicity, the picture isn't clear, it seems that none of these specific variants are associated with hypertension in any of the global studies, ruling out the possibility of a common genetic mechanism for the onset of hypertension and SARS-CoV-2 infection.

Of course the rate and course of infection rely on the effects of both biology and behaviour, and in both of these gender is a significant factor. It is already well established that the immune systems of men and women respond to the challenges of infection rather differently, particularly during a woman's period of fertility. It appears that a woman's immune system responds more quickly and more vigorously to infectious agents, this probably represents an adaptation to protect a fetus, this increased reactivity might also explain why women are more likely to suffer autoimmune conditions later in life. I understand that there are also some important interactions between oestrogen and the ACEII proteins which might also be significant, but I'm afraid that isn't something I'm familiar with.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314689/
 
  • Informative
  • Like
Likes pinball1970 and BillTre
  • #153
The new omicron subvariant has rapidly overtaken other strains, including EG.5 aka Eris, to become the dominant variant in the U.S. As of late October, HV.1 is responsible for more than a quarter of all COVID-19 cases, and health officials are monitoring the new variant amid concerns of a winter COVID-19 surge.

HV.1 accounted for an estimated 25.2% of new COVID-19 cases during the two-week period ending Oct. 28, according to the latest data from the U.S. Centers for Disease Control and Prevention.

After HV.1, the next most common variant in the U.S. was EG.5, which made up 22% of cases, followed by FL.1.5.1 or “Fornax,” and XBB.1.16 or “Arcturus.” (Globally, EG.5 is still the dominant strain, according to the World Health Organization.)

All of the most prevalent COVID-19 strains in the U.S. are offshoots of omicron, which first emerged in November 2021.
https://www.msn.com/en-us/health/ot...hese-are-its-most-common-symptoms/ar-AA1jJniO

HV.1 is part of the omicron family. “You can almost think of HV.1 as a grandchild of omicron,” says Schaffner. HV.1 is a sublineage of omicron XBB.1.9.2 and a direct descendent of EG.5, according to the CDC's SARS-CoV-2 lineage tree.

. . .
However, there are a few highly mutated strains which have set off alarm bells. These include BA.2.86 or Pirola, which has an extra 36 mutations that differentiate it from XBB.1.5., and a newer variant called JN.1, which has one more mutation than Pirola.

Fortunately, neither BA.2.86 nor JN.1 are common in the U.S. right now, according to the CDC — JN.1 is so rare that it makes up fewer than 0.1% of SARS-CoV-2 cases.

As for HV.1, it rapidly gained steam after it was first detected this past summer. In late July, HV.1 accounted for just 0.5% of COVID-19 cases in the U.S., CDC data show. By Sept. 30, HV.1 made up 12.5% of cases, and by November, it was the dominant strain.

The new boosters have been reformulated to target omicron XBB.1.5, which was the dominant COVID variant for most of 2023. While XBB.1.5 has since been overtaken by HV.1, Eris, Fornax and Arcturus, it is still closely related to these newer strains.
 
Last edited:
  • Informative
Likes pinball1970
  • #154
kyphysics said:
I didn't get RSV yet either. I'm going to get 1 vax every 2 weeks. . .flu ---> RSV ---> tetanus (last one was 25+ years ago) ---> Hep B ---> Pneu.

Hopefully that catches me up with everything by December. I might combine a few, but just want to research to see it's okay (since I have some complicated diabetes).
RSV not available in the UK till June this year. I was not offered it with my flu/Covid jab last month.
I will discuss with my GP next check up.
 
  • #155
pinball1970 said:
RSV not available in the UK till June this year. I was not offered it with my flu/Covid jab last month.
I will discuss with my GP next check up.
I got my flu shot w/ zero side-effects (I've never had any ever. . .only with the COVID shots). I will get tetanus (not RSV) next week.
 
  • Like
Likes pinball1970 and berkeman
  • #156
COVID will likely reach levels in December not yet seen this year, combining with surges of flu, RSV, and other pathogens for a winter not so different from last year’s “tripledemic,” experts say.
https://fortune.com/well/2023/12/01...ic-tripledemic-winter-2023-respiratory-virus/


EFD giving some winter warnings that fit with some recent news. My state of Virginia is seeing "very high" levels of COVID in sewage samples. Lots of people filling up E.R.s lately (I drive by every day and volunteered at one for three years here).
 
  • Sad
Likes pinball1970
  • #157
JN.1 was first detected in the U.S. in September. It had previously been classified with BA.2.86, or Pirola, a descendant of the omicron family, which some researchers early on worried could pose risks, but cases have recently declined in CDC estimates. In contrast, the original omicron variant overwhelmed hospital systems in 2022.

So far, it appears JN.1 doesn’t present a greater risk. Vaccination and previous infection also appear to help reduce the risk of serious illness from JN.1.
https://news.yahoo.com/growing-covid-19-variant-taken-184948041.html
According to the CDC, Louisiana and South Carolina are currently facing "very high levels" of respiratory illnesses. Meanwhile, New York, North Carolina, Georgia, Florida, Alabama, Mississippi, Tennessee, Texas, California, New Jersey, Nevada, New Mexico, Colorado, and Wyoming are witnessing "high levels" of respiratory illnesses. Additionally, eight more states and Washington, D.C., are showing an upward trend at a moderate level.

High percentages of positive COVID-19 cases, emergency department visits, and hospitalizations are reported nationwide, with a total of 22,513 admissions in the past week.

Furthermore, the nationwide rates of emergency department visits and hospitalizations due to influenza are on the rise. Simultaneously, hospitalization rates for RSV are also increasing among both young children and older adults.
https://www.msn.com/en-us/health/ot...y-high-respiratory-illness-levels/ar-AA1lsJ1l
 
Last edited:
  • #158
 
  • #159

New, highly mutated COVID variants ‘Pirola’ BA.2.86 and JN.1 may cause more severe disease, new studies suggest​

https://fortune.com/well/2024/01/08...1-more-severe-disease-lung-gi-tract-symptoms/
Highly mutated COVID variant BA.2.86—close ancestor of globally dominant “Pirola” JN.1—may lead to more severe disease than other Omicron variants, according to two new studies published Monday in the journal Cell.

In one study, researchers from Ohio State University performed a variety of experiments using a BA.2.86 pseudovirus—a lab-created version that isn’t infectious. They found that BA.2.86 can fuse to human cells more efficiently and infect cells that line the lower lung—traits that may make it more similar to initial, pre-Omicron strains that were more deadly.

In the other study, researchers in Germany and France came to the same conclusion. “BA.2.86 has regained a trait characteristic of early SARS-CoV-2 lineages: robust lung cell entry,” the authors wrote. The variant “might constitute an elevated health threat as compared to previous Omicron sublineages,” they added.
 
  • Like
  • Wow
Likes pinball1970 and Astronuc
  • #160
kyphysics said:
New, highly mutated COVID variants ‘Pirola’ BA.2.86 and JN.1 may cause more severe disease, new studies suggest
I read the same article, which was accompanied by a video.

A medical researcher mentions that BA.2.86 is a variant of Omicron, but may cause more severe disease, partly for what cells it attacks and it being more efficient at binding and infecting certain cells. BA.2.86 is phylogenetically distinct from Omicron XBB lineages with 30 more mutations on the spike protein, whereas JN.1 has L455 mutation on the spike protein and 3 non-S mutations, so more transmissibility and immune evasive property.

BA.2.86 seems to favor cells in the lungs (article mentions lower lung), while JN.1 may favor cells in the GI tract (intestines).

I also read a brief summary suggesting that SARS-Cov2 can damage mitochondria in the cells it attacks, which perhaps is responsible for long-Covid symptoms in some. I since found the following:

SARS-CoV-2 can cause lasting damage to cells’ energy production
https://www.nih.gov/news-events/nih...-cause-lasting-damage-cells-energy-production

Tissue samples taken during autopsies from the heart, kidney, liver, and lymph nodes continued to show suppression of these mitochondrial genes long after the virus had been cleared from the body. The reason for this continued suppression is unclear. In tandem with reduced mitochondrial function in these tissues, the researchers saw an upregulation of genes related to cellular stress.

“The continued dysfunction we observed in organs other than the lungs suggests that mitochondrial dysfunction could be causing long-term damage to the internal organs of these patients,” Wallace says.

https://www.nih.gov/news-events/nih-research-matters/toward-deeper-understanding-long-covid
 
  • Informative
  • Like
Likes Laroxe, Nik_2213 and dlgoff
  • #161
Tangential, the prospect of another new, nasty Covid variant coming through seems unlikely to change vaxx attitudes before distancing / masking re-introduced...

Based on casual enquiry --'NO Control Group'-- around usual dozen or so immediate neighbours and acquaintances, we again divide into my 'fully vaccinated' faction --Covid, Seasonal Flu & Decadal Pneumonia-- and the minimally vaccinated rest, be they out-right anti-vaxxers, efficacy disbelievers and/or 'Couldn't Be Bothered'...

Upside, UK is safely through the Winter Solstice, past the peak of family gatherings and crowd-drawing, virus-spreading 'Winter Sales'. Down-side, IIRC, waste-water monitoring shows an unsettling rise in viral loads...

Take Care Out There !!
 
  • #162
Nik_2213 said:
Tangential, the prospect of another new, nasty Covid variant coming through seems unlikely to change vaxx attitudes before distancing / masking re-introduced...

Based on casual enquiry --'NO Control Group'-- around usual dozen or so immediate neighbours and acquaintances, we again divide into my 'fully vaccinated' faction --Covid, Seasonal Flu & Decadal Pneumonia-- and the minimally vaccinated rest, be they out-right anti-vaxxers, efficacy disbelievers and/or 'Couldn't Be Bothered'...

Upside, UK is safely through the Winter Solstice, past the peak of family gatherings and crowd-drawing, virus-spreading 'Winter Sales'. Down-side, IIRC, waste-water monitoring shows an unsettling rise in viral loads...

Take Care Out There !!
A study in the Lancet, deaths from under vaccination.

"7,000 people were hospitalized or died from COVID-19 in the UK during the summer of 2022 because they had not received the recommended number of vaccine doses"

Full article

https://medicalxpress.com/news/2024-01-uk-wide-reveals-people-covid.html

Lancet publication.

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)02467-4/fulltext (the DOI link did not work)
 
  • #163
I think it's entirely predictable that we are seeing new variants, in fact there are many more around than what we see reported, we only see reports when one variant starts to be seen more frequently. Identified genetic changes don't tell us very much really, they happen all the time, particularly in RNA viruses & most of these will either be damaging to the virus or largely irrelevant. Even the identified changes in the genome that affect the structure of the spike protein may not cause predictable changes. The concern that the Pirola variant may have advantages in gaining cell entry don't seem likely, none of the Omicron variants appear to have any difficulty with this, in some cases the incubation period between exposure and symptom onset can be 1-2 days, that's fast.

I will also say that these studies on the risk of severe outcomes with different vaccine doses are less than helpful, in fact the lancet article might as well have been written in Russian, and I don't speak Russian. They seem to have forgotten to mention the study population of roughly 64 million, and I couldn't find any overall hazard ratio. They also fail to make what they mean by undervaccinated, the guidelines at the time specified different numbers of vaccinations for different age groups. At the time of the study to be fully vaccinated was to have received two with the third considered a booster dose. A second booster became available for most people in September of 2022, after this study.

I suspect attempting to provide some sort of general estimate of risk, when we consider the range of significant variables, was a rater pointless exercise. I've provided a link to a rather less opaque study that looks at similar issues after the 2nd booster, naturally they use different cut off points, so comparisons are useless. It does however make some interesting points, the first is that even after the 2nd booster, when compared to people under 50, those over 80 were 10.43 times more likely to experience severe outcomes. The study also demonstrated the effects of the time between vaccinations, which is increasingly identified as important. People receiving the booster after a period of less than 24 weeks from a previous vaccination were actually at increased risk, I've seen it suggested that a vaccination given too soon can actually damage the immune status. Finally, they report the effects of BMI on risk suggesting

For BMI, we found that those classified as underweight (BMI<18.5) were at greater risk of a severe outcome
than those classified as overweight (BMI 25.0–29.9). Additionally, those classified as a healthy weight (BMI 18.5–24.9) were 1.36(1.25–1.48) times more likely to experience a severe outcome than those classified as overweight. This seems to match the findings of Fragal on BMI and mortality, perhaps you need some stored calories to survive in intensive care. Obesity is still a significant risk.https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(23)00235-1/fulltext
 
  • Informative
  • Like
Likes BillTre and pinball1970
  • #164
Laroxe said:
I think it's entirely predictable that we are seeing new variants, in fact there are many more around than what we see reported, we only see reports when one variant starts to be seen more frequently. Identified genetic changes don't tell us very much really, they happen all the time, particularly in RNA viruses & most of these will either be damaging to the virus or largely irrelevant. Even the identified changes in the genome that affect the structure of the spike protein may not cause predictable changes. The concern that the Pirola variant may have advantages in gaining cell entry don't seem likely, none of the Omicron variants appear to have any difficulty with this, in some cases the incubation period between exposure and symptom onset can be 1-2 days, that's fast.

I will also say that these studies on the risk of severe outcomes with different vaccine doses are less than helpful, in fact the lancet article might as well have been written in Russian, and I don't speak Russian. They seem to have forgotten to mention the study population of roughly 64 million, and I couldn't find any overall hazard ratio. They also fail to make what they mean by undervaccinated, the guidelines at the time specified different numbers of vaccinations for different age groups. At the time of the study to be fully vaccinated was to have received two with the third considered a booster dose. A second booster became available for most people in September of 2022, after this study.

I suspect attempting to provide some sort of general estimate of risk, when we consider the range of significant variables, was a rater pointless exercise. I've provided a link to a rather less opaque study that looks at similar issues after the 2nd booster, naturally they use different cut off points, so comparisons are useless. It does however make some interesting points, the first is that even after the 2nd booster, when compared to people under 50, those over 80 were 10.43 times more likely to experience severe outcomes. The study also demonstrated the effects of the time between vaccinations, which is increasingly identified as important. People receiving the booster after a period of less than 24 weeks from a previous vaccination were actually at increased risk, I've seen it suggested that a vaccination given too soon can actually damage the immune status. Finally, they report the effects of BMI on risk suggesting

For BMI, we found that those classified as underweight (BMI<18.5) were at greater risk of a severe outcome
than those classified as overweight (BMI 25.0–29.9). Additionally, those classified as a healthy weight (BMI 18.5–24.9) were 1.36(1.25–1.48) times more likely to experience a severe outcome than those classified as overweight. This seems to match the findings of Fragal on BMI and mortality, perhaps you need some stored calories to survive in intensive care. Obesity is still a significant risk.https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(23)00235-1/fulltext
I need to digest this. Informative as usual sir.
 
  • Like
Likes Laroxe and BillTre
  • #165
My son tested positive for Covid on Wednesday this week, and I had a positive test result today. We probably have JN.1. My son likely brought it home from work, or a day out with a co-worker. While he generally wears a mask at work (one the few), he has to remove his mask to eat and drink.

My son was last at work on Tuesday last week and with a co-worker on Wednesday, last week. He started to show symptoms Sunday evening with a cough and congestion. He worked Tuesday, then only half of a shift on Wednesday this week. He was feeling very fatigued by Wednesday, and arranged for test Wednesday afternoon. I started showing symptoms last night - chills and some congestion.

This morning - no fever or cough, but congestion, sinus pressure, definitely fatigue, slightly runny nose, and mild headache. I will start on Paxlovid.

So far, it feels like a bad head cold - very unpleasant. So, my day zero was yesterday, the today is considered Day 1 for symptoms - another 4 days to go as symptoms are supposed to subside.

I had the most recent booster in mid October. My son has not yet received the latest booster.
 
Last edited:
  • Sad
  • Like
Likes Laroxe and pinball1970
  • #166
I know that during the pandemic several people watched John Campbell's videos on COVID data. Sadly, Campbell seems to have sunk into a full-scale COVID "big pharma" conspiracy theorist and ardent climate change denier. I won't link to the video that YouTube just served up, but it was a bit of a shock.
 
  • Sad
  • Like
Likes OmCheeto, Astronuc and pinball1970
  • #167
PeroK said:
Sadly, Campbell seems to have sunk into a full-scale COVID "big pharma" conspiracy theorist and ardent climate change denier.
That's disappointing.

I can attest to the effectiveness of masks, vaccines and Paxlovid. I'm on day 3 of taking Paxlovid, starting last Friday evening after testing positive for Covid. Thursday evening, I was showing symptoms similar to a normal common (Rhinovirus/Coronavirus) cold - mostly congestion, runny nose, slight headache and chills; I also has a slight and infrequent cough. I called my doctor on Friday morning, but couldn't get an appointment until Friday afternoon. I tested positive, so the doctor prescribed Paxlovid, and I was able to start taking the medication Friday evening. On Friday, I was having much stronger symptoms including fatigue, but fortunately, no strong cough. After 24 hours on Paxlovid, the symptoms became muich milder, and the congestion and runny nose abated, and now two days later, I feel more or less normal.

My son had tested postive on Wednesay afternoon. He was not prescribed Paxlovid, since it is currently reserved for those under 18, 50 or older, and those at risk of medical complication, or who have some health vulnerability. I think he should have insisted, since he was quite ill, and this was his second time, and his symptoms were more severe, including changes to his senses of smell and taste, and he had a fever and cough. He did not get the recent booster.

My wife tested negative for Covid on Friday evening, but tested again Saturday morning with a positive result. She started showing symptoms Friday night into Saturday.

We always wear masks in public and my son wears a mask at work, but he does remove the mask to eat and drink. He either got the virus at work, or Wednesday (12 days ago) at lunch with a coworker, and was probably infection on the following Saturday when we drove about 90 miles to visit a museum, and returned during the late afternoon. In public we all wore masks at the museum, but not during the car ride.
 
  • #168
Astronuc said:
That's disappointing.
One of the things that frustrates me most is to see two old men (in their 70's) trash climate science when they are not going to have to live with the consequences.
 
  • Like
Likes pinball1970 and BillTre
  • #169
PeroK said:
I know that during the pandemic several people watched John Campbell's videos on COVID data. Sadly, Campbell seems to have sunk into a full-scale COVID "big pharma" conspiracy theorist and ardent climate change denier. I won't link to the video that YouTube just served up, but it was a bit of a shock.
I would be one of those who watched his videos religiously. Then one day, he stopped making sense. One of his latest 'things' is 'excess deaths'. I suspect it's one of those 'it's outside his field of expertise so he's getting it VERY wrong' type of things. Not that I'm even remotely familiar with the topic, but after a few hours of analysis, I can make 'excess deaths' numbers do whatever I want.

Yup. Between 2009 and 2017, the number of deaths in the U.S. increased by 41,800 deaths per year. If you follow that trend through 2023, the number of people who should have died for the years 2020 through 2023 should have been 11.84 million. Yet when you ignore Covid deaths only 11.78 million died during that period.

Of course, this is out of my field of expertise, so everyone should ignore me too.

Interestingly, the CDC uses the year 2017 through 2019 as their baseline. It's interesting because fewer people died in 2019 compared to 2018, and was effectively flat from 2017 through 2019. In their scenario, any increase in deaths shows up as 'excess deaths'. So I would ignore them also.
Doctors doing maths. Ha!
 
  • #170
Astronuc said:
That's disappointing.

I can attest to the effectiveness of masks, vaccines and Paxlovid. I'm on day 3 of taking Paxlovid, starting last Friday evening after testing positive for Covid. Thursday evening, I was showing symptoms similar to a normal common (Rhinovirus/Coronavirus) cold - mostly congestion, runny nose, slight headache and chills; I also has a slight and infrequent cough. I called my doctor on Friday morning, but couldn't get an appointment until Friday afternoon. I tested positive, so the doctor prescribed Paxlovid, and I was able to start taking the medication Friday evening. On Friday, I was having much stronger symptoms including fatigue, but fortunately, no strong cough. After 24 hours on Paxlovid, the symptoms became muich milder, and the congestion and runny nose abated, and now two days later, I feel more or less normal.

My son had tested postive on Wednesay afternoon. He was not prescribed Paxlovid, since it is currently reserved for those under 18, 50 or older, and those at risk of medical complication, or who have some health vulnerability. I think he should have insisted, since he was quite ill, and this was his second time, and his symptoms were more severe, including changes to his senses of smell and taste, and he had a fever and cough. He did not get the recent booster.

My wife tested negative for Covid on Friday evening, but tested again Saturday morning with a positive result. She started showing symptoms Friday night into Saturday.

We always wear masks in public and my son wears a mask at work, but he does remove the mask to eat and drink. He either got the virus at work, or Wednesday (12 days ago) at lunch with a coworker, and was probably infection on the following Saturday when we drove about 90 miles to visit a museum, and returned during the late afternoon. In public we all wore masks at the museum, but not during the car ride.
Talking of Paxlovid I came across this article

https://medicalxpress.com/news/2024-01-antiviral-medication-covid-patients-access.html

"Lemieux and her colleagues have modified a specific area of the molecule in the active drug that enables it to stay in the system—meaning an additional "booster" drug is not necessary. This could help widen the use of the drug and allow more people to safely treat their COVID infection"

The paper was published in Aug so may have mentioned somewhere else on PF

https://pubs.acs.org/doi/10.1021/acsbiomedchemau.3c00039
 
  • Informative
  • Like
Likes Astranut and Tom.G
  • #171
I agree that John Campbells youtube video's seem to have become focussed on the issue of excess deaths, which he thinks are being ignored. That's not my impression at all, there is certainly an issue in the possible longer term harm associated with Covid and the its effects on healthcare generally but there is a lot of work going on looking at the way this virus interacts with our immune system. The fact remains that the real threat is from the disease itself and he seems to be ignoring the realities of risk assessment.

I have no problem with challenges to the scientific evidence, science is based on scepticism really and challenges that address issues about how the data was collected, data analysis and how conclusions are reached can be very useful. Even the more common questions that require clearer explanations have an important function and I think the people who pay for the science, often the public, have a right to ask. Unfortunately, it's become common for people to challenge science simply based on whether they agree with the results, and they leave no room for discussion about the methods etc. This isn't really a science issue, but current culture has presented it as something that the people in science have to address, usually they can't. What Campbell talks about is technically correct, but with no context it's meaningless, the problem is that he is not a virologist or immunologist and these are very complex issues, there are far better sources out here, he's moved into the political domain. These days the public see's our political masters as dishonest and self-serving, so politicians have been trying to suggest that their actions are based in science to borrow at least some of the credibility of scientists. Unfortunately, what we see instead is that the public now see science as part of government and deserving of the same level of trust and credibility. It's interesting that lately we have also seen some large environmental groups getting increasing amounts of government funding and being given power through advisor roles. It has become clear that many of the actions taken in order to manage climate change through subsidies have given a clear economic advantage to the wealthy at a cost to the poor. This has led to some conflict between some environmental groups, an increased erosion of support for climate action and hostility to activists. None of this seems to be about the science.
 
  • Like
Likes BillTre, OmCheeto and Astronuc
  • #172
pinball1970 said:
Talking of Paxlovid I came across this article

https://medicalxpress.com/news/2024-01-antiviral-medication-covid-patients-access.html

"Lemieux and her colleagues have modified a specific area of the molecule in the active drug that enables it to stay in the system—meaning an additional "booster" drug is not necessary. This could help widen the use of the drug and allow more people to safely treat their COVID infection"

The paper was published in Aug so may have mentioned somewhere else on PF

https://pubs.acs.org/doi/10.1021/acsbiomedchemau.3c00039
That's an interesting twist on chemistry, replacing H with D in a molecule to affect its function.

The Paxlovid I take has 1 capsule of ritonavir and the active ingredient, which attaches to the virus is nirmatrelvir.

I also took aspirin, which it turns out is recommended for those who are prone to clotting from SARS-Cov-2. My wife's doctor indicated that many severely ill patients have thromboses, and not just pulmonary or cardio thromboses, but potentially the brain and other organs. This has been well documented.

The current variant, JN.1, seems mostly to involve the nose, sinues and throat, and potentially the olfactory system. However, it can spread to the lungs and cause more severe effects. I expect the virus can get into the blood stream and travel anywhere. Our region is seeing a marked increase in hospitalizations and some fatalities from/with Covid, at a level of about 10x that of influenza cases.

My wife found the following at Yale Medicine
Paxlovid is an antiviral therapy that consists of two separate medications packaged together. When you take your three-pill dose, two of those pills will be nirmatrelvir, which inhibits a key enzyme that the COVID virus requires in order to make functional virus particles. After nirmatrelvir treatment, the COVID virus that is released from the cells is no longer able to enter uninfected cells in the body, which, in turn, stops the infection. The other is ritonavir, a drug that was once used to treat HIV/AIDS but is now used to boost levels of antiviral medicines.

As a COVID-19 treatment, ritonavir essentially shuts down nirmatrelvir’s metabolism in the liver, so that it doesn’t move out of your body as quickly, which means it can work longer—giving it a boost to help fight the infection.
https://www.yalemedicine.org/news/13-things-to-know-paxlovid-covid-19

The article answers questions like When should one take Paxlovid? Answer: Paxlovid should be taken within five days of developing symptoms.

I started taking it within 24 hours of onset of symptoms, which were typical of a common cold, but I knew that my son had tested positive. Otherwise, I would have assumed normal causes of a runny nose and sinus congestion. Similarly, my wife would have assumed normal causes for her symptoms, which were developing 24 hours of mine. Incidentally, my wife did an at home test, which gave a negative result last Friday evening; on Saturday morning, she did a subsequent test, which yielded a positive result. She was able to get a prescription for Paxlovid on Saturday morning and began the 5 day treatment.

Another question: Is Paxlovid similar to Tamiflu? Answer:
Tamiflu is an antiviral drug that reduces flu symptoms. Both are prescription-only oral antiviral pills given early in illness.

Tamiflu is taken twice a day for five days, and it must be started within 48 hours of flu onset. “When you give a patient Tamiflu beyond that, it doesn’t really change the course of their flu,” Dr. Roberts says.

But there are also differences between the two, starting with the way they were studied, Dr. Topal adds. Researchers showed that Paxlovid can prevent hospitalization and death. But since influenza causes fewer severe cases, clinical trials focused on whether Tamiflu could shorten the length of flu illness—which it did, he says.

I took Tamiflu when I had the flu, which was the only year I did not get the flu vaccine (which I have done every year since). I was quite ill with a high fever ~102.4°F (39°C) on a Sunday evening with a severe cough and sneezing. Within 12 hours of taking Tamiflu within 24 hours of onset of symptoms, the severity of the illness diminished and my fever was reduced to less than 38°C. I also took aspirin for the fever, which abated 48 hours after beginning Tamiflu.
 
  • Informative
  • Like
Likes Laroxe and pinball1970
  • #174
 
  • Informative
Likes pinball1970
  • #175
nsaspook said:
https://www.wsj.com/health/wellness/covid-guidelines-2024-cdc-symptoms-contagious-cdefb6b8
It’s Official: We Can Pretty Much Treat Covid Like the Flu Now. Here’s a Guide.
New guidelines from the CDC Friday bring Covid precautions in line with with those of other respiratory viruses


https://www.cdc.gov/respiratory-viruses/background/index.html


Published in Journal of the American Medical Association, Yesterday.

According to this Covid is still more deadly than influenza.

https://medicalxpress.com/news/2024-05-nothingburger-reputation-covid-deadlier-flu.html
 
  • #176
pinball1970 said:
Published in Journal of the American Medical Association, Yesterday.

According to this Covid is still more deadly than influenza.

https://medicalxpress.com/news/2024-05-nothingburger-reputation-covid-deadlier-flu.html
The COVID-19 patients were a little older, on average, than the flu patients (73.9 versus 70.2 years old), and they were less likely to be current or former smokers. They were also more likely to have received at least three doses of COVID-19 vaccine and less likely to have shunned the shots altogether.

Yet after Al-Aly and his colleagues accounted for these differences and a host of other factors, they found that 5.7% of the COVID-19 patients died of their disease, compared with 4.2% of the influenza patients.

And it's not like the flu is a trivial health threat, especially for senior citizens and people who are immunocompromised. It routinely kills tens of thousands of Americans each year, CDC data show.

"Influenza is a consequential infection," Al-Aly said. "Even when COVID becomes equal to the flu, it's still sobering and significant."


I don't think that equating Covid with the flu by the CDC is an attempt to downplay it. It's IMO reasonable to normalize COVID-19 with flu now.
 
  • Informative
  • Like
Likes Tom.G, morrobay and pinball1970
  • #177
And I dare say high time. Both covid and the flu have always been a threat for those with obesity and related life style induced co morbidities.
 
  • #178
I went to the clinic a couple of months ago and based on the following information I've been collecting, I opted for the pneumonia vaccine. My first ever! Before all the Covid hoo-ha, I don't think I even knew that pneumonia was such a prominent killer, nor that there was even a vaccine available.

Flu Pneumonia Covid deaths per CDC. 2024-05-17 at 00.59.11.png

week (40 ≈ Oct 1, 2023)​


source of data: https://gis.cdc.gov/grasp/fluview/mortality.html
 
  • Like
  • Informative
Likes pinball1970, Astronuc and BillTre
  • #179
I expect that the general interest in the Covid variants will fade soon, the virus will continue to mutate, as does the flu virus, but no one really talks about the flu variants, unless its a pandemic variant. I suspect we will see variations in the mortality estimates, it happens with flu but generally the figures will be similar.
I suspect the figures suggesting that there is a higher mortality in the vaccinated are simply a reflection of the higher numbers of the population being vaccinated, particularly those most at risk.
It's very useful that OmCheeto has drawn attention to other infections, it is in fact other infections that kill most people who have been weakened by a prior viral infection.
While I have little doubt that Covid, which has some interesting effects on our immune system, will come up with some more surprises, I'm hopeful the threat will fade, at least until the next pandemic. At least we have learned a great deal from this episode, which should increase our resilience.
 
  • Like
  • Informative
Likes nsaspook, pinball1970 and Tom.G
  • #180
The good news is that in the early spring of 2024, COVID-19 cases were down, with far fewer infections and hospitalizations than were seen in the previous winter. But SARS-CoV-2, the coronavirus that causes COVID, is still mutating. In April, a group of new virus strains known as the FLiRT variants (based on the technical names of their two mutations) emerged.

The FLiRT strains are subvariants of Omicron. One of them, KP.2, accounted for 28.2% of COVID infections in the United States by the third week of May, making it the dominant coronavirus variant in the country; another, KP.1.1, made up 7.1% of cases.
https://www.yalemedicine.org/news/3-things-to-know-about-flirt-new-coronavirus-strains

Laroxe said:
I'm hopeful the threat will fade, at least until the next pandemic. At least we have learned a great deal from this episode, which should increase our resilience.
Enough people got vaccinated (and boosted) that perhaps another Covid pandemic is mitigated. The impact of influenza is likely mitigated by vaccinations, particularly for those 65 years and older.


Four years ago, when we were starting to learn more about SARS-Cov2
https://www.sciencedirect.com/science/article/pii/S2090123220300540
 
  • #181
I've lost track of the variant evolution. However, Omicron descendant, KP.3.1.1 is apparently dominant in the US. I've heard that a number of public officials developed Covid during the last month.

KP.3.1.1, of the Omicron family, is now the predominant SARS-CoV-2 variant circulating in the United States, having overtaken its parent linage KP.3 and previous KP.2 variants. KP.3.1.1 is the only major variant increasing in proportion nationally.
https://www.cdc.gov/ncird/whats-new/kp-3-1-1-is-the-predominant-variant.html

I just received the latest booster from Moderna (my 5th booster); my wife and one also got the same booster. My initial vaccine and subsequent boosters have been Pfizer/BioNTech. I had no significant reaction, only soreness near the injection site. My son also got the same Moderna vaccine, and he did feel some fatigue and discomfort; he had skipped the previous booster, which I received last October.

We all had Covid in January. My wife and I took Paxlovid for 5 days, while my son did not (according to current protocols). My wife and I had mild symptoms, similar to having an allergy or mild cold. My son, who had the booster about the same time I did, had symptoms of a strong cold, including coughing, fever and fatigue. After my wife and I finished the Paxlovid, the symptoms did become somewhat stronger with a so-called post-Paxlovid rebound. I think Paxlovid should be used for 7 days rather than 5 days.

We now get Covid and influenza vaccines at the same time, usually in October, but this year in September. I will probably get the vaccines for RSV, pneumococcal bacteria and shingles soon.

We generally wear N95 masks when entering public spaces, e.g., supermarket or shops. We seldom eat in restaurants preferring to get take-out.
 
  • Like
Likes OmCheeto, Tom.G, Laroxe and 1 other person
  • #182
Yep! KP 3-1-1 appears to be the new kid on the block and is becoming the new dominant variant. Its getting increasingly difficult to make sense of what gives these variants a selective advantage, I know that its suggested to have a shorter incubation period, but all the Omicron variants seem to share this and the difference doesn't seem that significant and despite the claims of increased antibody resistance, we all make quite a number of different antibodies and the variants are likely to only really reduce the effectiveness of a few. The current information on the UK data dashboard suggests a small increase in the number of cases (4.3% over the last 7 days) while deaths have fallen by 20.9% and hospital admissions by 6.6%, though there is a delay before the number of cases affect the other numbers.

This does sort of call into question the need to take precautions against infection, continued exposure to the virus would facilitate the maintenance of high levels of more variant specific antibodies. We are still playing catchup with the vaccines, by the time a new vaccine is ready there is often a new variant, luckily the vaccines still work, the effect of the observed genetic changes in the viruses doesn't seem terribly significant. However, we do know that to prevent the development of symptoms after exposure requires very high antibody levels, levels that even when achieved are short-lived, so increased exposure might be useful.

Unfortunately, we simply can't make adequate risk assessments based on cost benefit analysis, particularly for people considered to be at high risk. At the moment, it would be a brave Dr. that would advise a patient considered to be at high risk to dispense with all their precautions. It still seems to be the case that vaccination is by far the most effective protection, its interesting that in the UK Paxlovid appears to be used far less frequently, but you wouldn't know this by looking at any effect on the mortality rates.

I know that there is the possibility that the new DNA vaccine from Novavax will provide a more persistent antibody response, and there are new inhaled vaccine boosters in trials that increase local tissue defences in the upper Resp. Tract, the usual point of viral entry. The trouble is that now it is increasingly difficult to collect the data needed to assess treatments and new vaccines, so progress has slowed considerably and these things are important in the preparations for the next pandemic. The results of the increased monitoring of novel pathogens has resulted in even more alarmist reporting, which might in fact be misleading.
 
  • Like
  • Informative
Likes pinball1970, OmCheeto, Tom.G and 1 other person
  • #183
An interesting conversation with Dr. Fauci was published a few days ago.

Dr. Anthony Fauci Shares Insights on His Career and Leadership of the NIAID
Published September 16, 2024
...
Neil S. Greenspan, MD, PhD;
This gets into the next question, which is — and I know you’ve been asked this by other interviewers, but I think it’s important to address how precisely to think about the effectiveness of the mRNA vaccines in limiting transmission, because people often talk about it in absolute terms that it either does or doesn’t, and I want to know if you would agree that — my take would be that even if it isn’t 100% able to prevent transmission, that doesn’t mean it’s not benefiting us by reducing the probability of transmission, or the scale of transmission.

A. Fauci;
No, I’m with you on that, because it doesn’t do it to the 90% or even 80% or 70%. It does have some impact on transmission, number one. However, that impact is short lived. So, if you start off with the ancestral strain that we made the vaccine against. In that trial, it likely had a reasonably good effect on transmission, not 93%, but reasonably good.

What we learned from experience, and you know the people who criticize the scientists and criticize the public health officials say, “You told us it was going to protect.”

We made an assumption, that protection would remain at a high level, and it didn’t. It was lower than we wanted to begin with, and it didn’t stay very long. What stayed long was the protection against severe disease leading to hospitalizations and death. That was reasonably durable, not measured in many years, but durable beyond a few months; whereas the protection against infection was lower than that against severe disease and was much less durable. But in answer to your question, that doesn’t mean there was no protection against infection. If you could get a little bit of mileage out of that, it would be worth it. So long as you don’t — now that we know what the results are — you don’t say it definitely is going to protect you against infection. It’s not. I’m a classic example of that. I’ve been vaccinated 6 times with the primary series, followed by a bunch of boosts. I’ve been infected 3 times.

So not only does vaccine (not fully protect), but hybrid immunity with vaccine plus infection didn’t protect me against getting infected. Three and a half weeks ago I had a very mild infection, but I still got infected. Now, given my age, if I didn’t have hybrid immunity, I might have died from the infection.

I find it interesting that the original vaccine had an efficacy of 95% and yet the average death rate for the last two years is 1/7th that of the average of the first two years (64,000 vs 420,000). I'm curious of the vaccination status of all those people that died.
(google google google)
And there we have it. Per Our World in Data, unvaccinated people are 4.7 times more likely to die than fully vaccinated people. (May 7, 2022 - April 1, 2023, all ages)

ps. Here's an updated graph of my dreadfully old 'trend in deaths' I posted in 'Random Thoughts' the other day. It looks as though if things don't improve, Covid will be the number two killer around the middle of next month. I left in the 2020 as it still amazes me how we went from 20 deaths per day to 2000 deaths per day in just 3½ weeks. Note that the 2020 plot dates do not match the x-axis but started on March 9th.


1726828064739.png
 
  • #184
Weekly deaths report is out at the CDC.
Not really much of a change from last week, trend-wise.
Now tied for the longest surge.
Makes me think I should get serious about getting the latest booster.

1726884293128.png
 
  • #185
Making sense of the data we have can be confusing, there are lots of different variables that effect how it can be interpreted. You say that the original vaccine had a 95% efficiency, I don't think that is what Fauci said, they were discussing the effectiveness of the vaccine on preventing transmission, and he commented that in the early days of vaccination against the original Covid variant it did have quite a good effect. The problem was that this effect didn't last long and rapidly disappeared with the new variants. In many places the first available vaccination doses were given to particular groups particularly those at high risk, these people are often already restricted in their social contacts, this really complicates the usefulness of the early data. Still, our world data is an excellent resource and often provides explanations of how the data can be used. I didn't see the part about the vaccinated being more likely to die, but I've seen similar claims, they do provide some guidance on the date which addresses this issue at:
https://ourworldindata.org/covid-deaths-by-vaccination

It does seem that a lot of commentators try to use the raw data on the numbers who die, but if you have a very large population that are vaccinated vs a small number of unvaccinated, the raw data tells you very little. Generally, when you look at the effect of the introduction of the vaccines on deaths, there is a very clear and dramatic reduction at the population level something which becomes even more obvious if we look at the effect on the elderly who are at greater risk. I have to say I'm not keen on the graphs you used, I wasn't aware that any of the causes of death were occurring at a steady rate and could be plotted as a straight line over time.
 
  • Like
Likes BillTre, OmCheeto, Astronuc and 1 other person
  • #186
Laroxe said:
Making sense of the data we have can be confusing, there are lots of different variables that effect how it can be interpreted. You say that the original vaccine had a 95% efficiency, I don't think that is what Fauci said, they were discussing the effectiveness of the vaccine on preventing transmission, and he commented that in the early days of vaccination against the original Covid variant it did have quite a good effect.
First off, I have a feeling we are going to end up in complete agreement on nearly everything, but will be talking past each other due to things like your expertise in medicine and my having never even taken a basic biology course.

My '95% efficacy' comment was from one of the original trials reported back in 2000 by the NEJM.

1727029443450.png




The problem was that this effect didn't last long and rapidly disappeared with the new variants.
agreed
In many places the first available vaccination doses were given to particular groups particularly those at high risk,
agreed
these people are often already restricted in their social contacts, this really complicates the usefulness of the early data.
agreed
Still, our world data is an excellent resource and often provides explanations of how the data can be used. I didn't see the part about the vaccinated being more likely to die
[bolding mine]​

agreed. Though I seem to sense that you implied that I said that, which is where we are going to have to disagree.
, but I've seen similar claims, they do provide some guidance on the date which addresses this issue at:
https://ourworldindata.org/covid-deaths-by-vaccination

It does seem that a lot of commentators try to use the raw data on the numbers who die, but if you have a very large population that are vaccinated vs a small number of unvaccinated, the raw data tells you very little. Generally, when you look at the effect of the introduction of the vaccines on deaths, there is a very clear and dramatic reduction at the population level something which becomes even more obvious if we look at the effect on the elderly who are at greater risk.
agreed
I have to say I'm not keen on the graphs you used, I wasn't aware that any of the causes of death were occurring at a steady rate and could be plotted as a straight line over time.
It's the simplest of maths. Take all the people who die in a year from a certain cause and divide by 365.
Beings that I consider most people are both mathematically and medically functionally illiterate, I draw a picture to explain what I'm trying to convey, as that's generally how I best understand things.

From my graph, I can see that currently, covid is killing the same number of people as diabetes.

So then, the question I now have is:

Given that the 'Our World in Data' data shows that people who are not vaccinated are ≈5 times more likely to die than vaccinated people, does my 64,000 average deaths indicate that....

5 out of 6 deaths are because of vaccine hesitancy, and hence 64,000/6 * 5 = 53,000 deaths were avoidable?

This is a question more for maths types, as I'm a low grade recreational mathematician.
 
  • Like
Likes Laroxe and BillTre
  • #187
OmCheeto said:
First off, I have a feeling we are going to end up in complete agreement on nearly everything, but will be talking past each other due to things like your expertise in medicine and my having never even taken a basic biology course.

My '95% efficacy' comment was from one of the original trials reported back in 2000 by the NEJM.

View attachment 351425




agreed

agreed

agreed

[bolding mine]​

agreed. Though I seem to sense that you implied that I said that, which is where we are going to have to disagree.

agreed

It's the simplest of maths. Take all the people who die in a year from a certain cause and divide by 365.
Beings that I consider most people are both mathematically and medically functionally illiterate, I draw a picture to explain what I'm trying to convey, as that's generally how I best understand things.

From my graph, I can see that currently, covid is killing the same number of people as diabetes.

So then, the question I now have is:

Given that the 'Our World in Data' data shows that people who are not vaccinated are ≈5 times more likely to die than vaccinated people, does my 64,000 average deaths indicate that....

5 out of 6 deaths are because of vaccine hesitancy, and hence 64,000/6 * 5 = 53,000 deaths were avoidable?

This is a question more for maths types, as I'm a low grade recreational mathematician.

First, my apologies if I misunderstood what you were saying about the effectiveness of vaccinations on mortality.

I assume your estimate of 64,000 deaths is based on the average monthly excess mortality in the US, if it isn't my 2nd set of apologies, but that's what I was looking at. While excess deaths may not provide an accurate number that can be attributed to Covid19, it's thought to represent a better estimate of the effects of the pandemic. In fact in the US in 2020 there were some 470,000 excess deaths (deaths in excess of the previous 5-year averages) while only 352,000 of these identified Covid as the primary cause of death.

I don't think we can talk about vaccine hesitancy as a cause of death, but that does lead us into another issue, particularly if we try to compare different causes. The fact is that deaths in people with Covid19 are often associated with multiple pathologies, and your example of diabetes is a good one. You mention that Covid kills as many people as diabetes,but diabetes in itself, these days is not the real cause of the associated deaths, it is the fact that it increases the risk of death from heart/arterial disease, kidney disease, various infections, various cancers etc. In fact, diabetes is a major risk factor in deaths from Covid19, Covid19 also increasing the risk of death from heart disease. Overall, the strongest associated risk from Covid19 is old age, this effect being an important factor in how effective vaccination is in inducing an immune response.

However, your overall assessment of the effectiveness does seem to be consistent with the data though with some important caveats. Once the vaccine became available because of both policy and education, those at greatest risk had a particularly high rate of vaccination, I would suggest that the demographics of the people who refuse vaccination is likely to be very different from the population averages. There is the added problem in that the virus itself changes which can have a direct impact on vaccine effectiveness and overall mortality, as does the improved care available and the availability of antivirals has an important effect on mortality.

I think we have to consider a lot of the information that has been used to produce many of the figures as essentially unreliable. The original figures reflected the early variants of the virus which we now know were much more likely to lead to serious disease, this was reflected in the mortality data. Over time, the virus appears to have become less virulent, even when we consider the potential changes to vaccine effectiveness. I'm left wondering how useful the various estimates actually were, it now appears that there were so many variables unknown or unconsidered. Weare now of course in a quite different situation in which the longer term effects of Covid19 as a cause of death in people of all ages.Its unlikely that there are many people that have avoided contact with the virus, so vaccination now has a much more nuanced effect, and yet excess deaths in the EU continues at levels around 5% above the expected level. While some of this can be attributed to the effects of Covid19 on healthcare, the reduction in monitoring and data collection is effectively preventing explaining the rest.
 
  • #188
And yet another variant, XEC

New COVID-19 XEC variant circulating just before fall
https://medicalxpress.com/news/2024-09-covid-xec-variant-circulating-fall.html
The new variant has sprouted from the omicron variant that developed in late 2021. Although XEC is new, Francois Balloux, director of the Genetics Institute at University College London, told the BBC that he would be surprised if it became the dominant variant throughout winter.

Centers for Disease Control and Prevention researchers indicate that the vaccine and booster shots should protect against the new variant. Here is what we know about the XEC variant and what you can do to stay healthy.

https://www.cdc.gov/covid/php/variants/index.html
https://covid.cdc.gov/covid-data-tracker/#datatracker-home


https://www.latimes.com/california/...hreat-for-winter-as-doctors-urge-vaccinations
XEC, which was first detected in Germany, is gaining traction in Western Europe, said Dr. Elizabeth Hudson, regional chief of infectious diseases at Kaiser Permanente Southern California. Like virtually all coronavirus strains that have emerged in the past few years, it’s a member of the sprawling Omicron family — and a hybrid between two previously documented subvariants, KP.3 and KS.1.1.
 
  • #189
Astronuc said:
And yet another variant, XEC
Here (Hungary) the last available vaccine was still against XBB, but validity of stock ran out at the end of last month.
Right now we have no available vaccine at all.
I foresee lot of 'fun' in the coming months :frown:
 
  • #192
Rive said:
Here (Hungary) the last available vaccine was still against XBB, but validity of stock ran out at the end of last month.
Right now we have no available vaccine at all.
I foresee lot of 'fun' in the coming months :frown:
Its not quite the problem you think it is, all of the vaccines continue to offer significant protection against the new variants, which is just as well as we are continually playing catch up with the new monovalent vaccines. By the time a new vaccine specific to the circulating variant is deployed, there is often a new variant in circulation. Luckily, it does seem that the new monovalent vaccines do have some advantages even against the newer variants, not used in the formulations available. It's not really the case that we have no vaccine available, even the original vaccine offers protection, it's just that the newer vaccines are marginally more effective. The fact that the majority of the population has had some exposure to the virus also helps, while antibody levels tend to fall quickly some parts of our immune response are far more enduring.
It's a bit of a shame that the latest vaccinations that use different technologies take far longer to evaluate, its hoped that Novavax, which has just become available, might lead to a more enduring effect, but I haven't seen any confirmation of this. There are others that might also offer much more significant advantages in terms of ease of handling, production, administration and immune responses offering improved cost-effectiveness.
 
  • #193
morrobay said:
And I dare say high time. Both covid and the flu have always been a threat for those with obesity and related life style induced co morbidities.
I think we need to be careful about any association of blame with risk. While lifestyle choices can be important in health they are often used in a highly selective way, based on poor quality evidence and without context. Remember that the most significant risk factor for both Covid and flu is age, with many of the other risk factors being strongly associated with age. Simply living a life, puts us at risk and evolution has predisposed us to be willing to or desire to take risks, fun fairs are in many ways based on this. When we are critical of others behaviours, we are assuming our choices are better, It's what politicians do to justify control.
Its been known for some time, and well before Covid19 appeared that Obesity has a direct effect on a persons willingness to seek care and the standard of the care they are likely to receive.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381543/
 
  • Like
Likes pinball1970 and BillTre
  • #195
A side effect, or consequence, of vaccines and isolation, or social distancing, may be the extinction of some strains of Influenza viruses.

October 17, 20249:30 AM ET - The flu shot is different this year, thanks to COVID
https://www.npr.org/sections/shots-...1-5155104/flu-shot-vaccine-b-yamagata-extinct

This year’s flu shot will be missing a strain of influenza it’s protected against for more than a decade.

That’s because there have been no confirmed flu cases caused by the Influenza B/Yamagata lineage since spring 2020. And the Food and Drug Administration decided this year that the strain now poses little to no threat to human health.

Scientists have concluded that widespread physical distancing and masking practiced during the early days of COVID-19 appear to have pushed B/Yamagata into oblivion.

From June 3, 2021 - Certain Strains Of Flu May Have Gone Extinct Because Of Pandemic Safety Measures

. . . every year when they get a flu shot that it protects against three or four different strains of flu. There's H1N1, which they'll know from the 2009 pandemic. There's H3N2. And there are two components that protect against influenza B viruses - B/Victoria and B/Yamagata.

It appears that a strain of Inlfuenza B may have become extinct.
 
  • Informative
Likes OmCheeto, berkeman and pinball1970
  • #196
Wasn't sure which of the 5 bazillion Covid threads to resurrect, but I chose this one, just because.
Anyways, I've decided to go public with my OCD finding that weekly flu deaths exceeded covid deaths for the first time since the Covid pandemic started.
Latest week nowcast death counts:
covid = 1150
flu = 1535

Covid vs Flu weekly deaths 2025-02-07 at 11.56.10.png


Not to say the flu strains are worse than covid. The seasonality of the flu is still keeping it in the basement as far as total annual deaths go.

annual flu vs covid deaths 2025-02-07 at 12.03.37.png

But, hmmm...., on a log scale, I may have to scratch my head some more on further predictions.

log scale annual Covid vs Flu deaths 2025-02-07 at 12.21.25.png
 
  • Like
  • Informative
Likes Tom.G and BillTre
  • #197
Thanks for the thread resurrection @OmCheeto, it needed a shot-in-the-arm. :wink:
 
  • Like
  • Haha
Likes pinball1970 and OmCheeto
  • #198
Tom.G said:
shot-in-the-arm
re-immunization
 
  • Like
Likes Tom.G and pinball1970
  • #199
James112 said:
It’s great that you got both shots! The updated Omicron booster does offer some protection against newer BA.xxxxxx variants, though effectiveness may vary depending on mutations. As for future boosters, it’s likely we’ll see an approach similar to flu shots, where vaccines are updated annually to target the most prevalent strains. With how fast variants emerge, periodic boosters may become the norm. Will be interesting to see how vaccine strategies evolve!

The community on PF said the same thing in 2021, bring Covid to season flu levels via the vaccine and the fact that everyone at some point will get Covid. So a mixture of vaccine and natural immunity- in that order!
 
  • #200
I thought this was interesting and discusses a number of important issues, the main findings are discussed in the conclusion if you want to save time.
Generally, it's true all the vaccines offer some protection, they all stimulate the production of a number of antibodies and so far there is no evidence of any variant evading them all. The high level of previous exposure, either with vaccines or by infection, provides a background in which serious disease is far less common. It's still the case that the age of the recipient is important, antibody levels fall quickly, and the virus hasn't settled into any predictable pattern of infections.
The vaccines targeting the new variants do appear to offer some advantages, but the new vaccines are always playing catchup to the appearance of new variants. As developments have slowed, we still haven't seen any data about the vaccines based on newer technologies and as funding has been reduced many manufacturers have been discontinuing developments.

https://www.sciencedirect.com/science/article/pii/S0163445324001117?via=ihub#sec0070
 
  • Like
Likes pinball1970
Back
Top